Patients pay for high margins of pharma firms
Patients in India end up paying more for medicines and all kinds of treatment as prevailing conditions do not allow the market to function …
Coal India to be probed for supply of low grade coal to sponge iron, power plants
Poor quality coal pollutes more; anti-competitive fuel supply agreements also under scanner of Competition Commission of India
Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion
The merger would lead to creation of the world's fifth-largest maker of generic drugs
Cabinet approves setting up of National Investment Board
Is renamed Cabinet Committee on Investment and will be headed by prime minister